Coronavirus COVID-19: Unexpected Consequences and New Treatment Approaches

The COVID-19 coronavirus infection pandemic, caused by the SARS-CoV-2 virus, has had an unprecedented impact on global healthcare. In addition to the acute course of the disease, increasing attention is being paid to long-term consequences that can affect virtually all organs and body systems. Understanding these complications and developing effective treatment strategies are becoming critical to improving patient prognosis and quality of life.

COVID-19 and the Respiratory System: Chronic Consequences

The SARS-CoV-2 virus primarily affects the respiratory system, causing acute respiratory symptoms. However, in patients, especially those with chronic lung diseases such as asthma or chronic obstructive pulmonary disease (COPD), COVID-19 can lead to severe and prolonged complications. These include pulmonary fibrosis and other pathological changes in lung tissue [1].

Studies show that patients with asthma and COPD are more susceptible to SARS-CoV-2 infection. At the same time, it is important to note that asthma treatment methods can affect the severity of COVID-19. For example, one study evaluated the effect of SMART (Single Maintenance and Reliever Therapy) compared to traditional therapy on COVID-19 severity in patients with moderate to severe asthma [7].

In combating lung tissue damage after COVID-19, regenerative medicine and cell therapy are a promising direction. The use of various types of stem cells can become an alternative approach for restoring damaged areas and compensating for lost organ functions. Due to their unique ability to differentiate and exhibit paracrine activity, these cells are capable of accelerating healing processes [1].

The Heart and Blood Vessels under Coronavirus Attack

The cardiovascular system is one of the most vulnerable targets for SARS-CoV-2. Patients with pre-existing cardiovascular diseases (CVD) or those who develop cardiac complications against the background of COVID-19 have a significantly higher risk of mortality [2, 5].

Key cardiovascular complications of COVID-19 include:

• Acute cardiac injury [2]
• Acute myocardial infarction (AMI) [2]
• Myocarditis (inflammation of the heart muscle) [2]
• Arrhythmias [2]
• Heart failure [2]
• Shock [2]
• Venous thromboembolism (VTE) and pulmonary embolism (PE) [2]

The mechanisms by which COVID-19 causes these complications are diverse and include direct viral damage, dysregulation of the renin-angiotensin-aldosterone system (RAAS), endothelial cell damage and thromboinflammation, a "cytokine storm," and a mismatch between oxygen demand and supply [2]. The European Society of Cardiology has developed guidelines for the diagnosis and management of CVD during the COVID-19 pandemic, emphasizing the importance of a comprehensive approach [5].

Kidneys: A Vulnerable Organ in COVID-19

The kidneys are also at significant risk in COVID-19. Patients with chronic kidney disease undergoing dialysis or following a kidney transplant have an increased risk of adverse outcomes from COVID-19 [3]. Moreover, severe COVID-19 significantly increases the risk of acute kidney injury (AKI) even in those who previously had no kidney problems [3, 8].

Acute kidney injury in COVID-19 can have both short-term and long-term consequences for nephrological health. The SARS-CoV-2 virus is capable of directly damaging kidney tissue (renal tropism), which exacerbates damage, especially in intensive care settings [8]. Nephrologists are actively working on developing and updating preventive, diagnostic, and therapeutic strategies to improve clinical outcomes in such patients [8].

Thyroid Gland and Oncology: Additional Risks

Coronavirus infection can also affect the endocrine system. Some studies indicate a link between COVID-19 and thyroid diseases, in particular, the development of thyroiditis or subacute thyroiditis [6].

As for cancer patients, they generally have a higher risk of contracting SARS-CoV-2, as well as a more severe course of COVID-19 and increased mortality [4]. A study conducted at a single thyroid disease treatment center showed that patients with thyroid cancer are also at risk of SARS-CoV-2 infection, although data on the specific severity of COVID-19 in this particular patient group require further study [4].

Promising Directions in Treatment and Rehabilitation

Given the multi-system nature of COVID-19 consequences, treatment and rehabilitation require a comprehensive and individualized approach. In addition to traditional treatment methods, new therapeutic opportunities are actively being researched:

• Regenerative medicine: The use of stem cells to repair damaged tissues, especially in the lungs, demonstrates great potential [1].
• Management of comorbidities: Optimizing the treatment of chronic conditions such as asthma, COPD, CVD, and kidney disease plays a key role in reducing the severity of COVID-19 and its complications [7].
• Prevention of thromboembolic complications: Given the high risk of thrombosis, special attention is paid to anticoagulant therapy and blood coagulation monitoring [2].
• Rehabilitation programs: Comprehensive programs including breathing exercises, physical activity, and psychological support are essential for restoring the functions of organs and systems after surviving the infection.

Continuous study of the pathophysiology of COVID-19 and its long-term effects allows for the development of more effective diagnostic, treatment, and rehabilitation strategies, improving the quality of life for millions of people worldwide.

Sources

1. Forthcoming complications in recovered COVID-19 patients with COPD and asthma; possible therapeutic opportunities. https://pubmed.ncbi.nlm.nih.gov/36320055/
2. Cardiovascular Manifestations and Mechanisms in Patients with COVID-19. https://pubmed.ncbi.nlm.nih.gov/33172748/
3. The COVID-19 pandemic: consequences for nephrology. https://pubmed.ncbi.nlm.nih.gov/33257872/
4. Thyroid cancer and COVID-19: experience at one single thyroid disease referral center. https://pubmed.ncbi.nlm.nih.gov/33638758/
5. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis. https://pubmed.ncbi.nlm.nih.gov/34864874/
6. COVID-19 and thyroid disease: An infodemiological pilot study. https://pubmed.ncbi.nlm.nih.gov/35721248/
7. Does asthma treatment influence COVID-19 severity? A comparative cohort study of SMART vs. Traditional therapy. https://pubmed.ncbi.nlm.nih.gov/42266192/
8. COVID-19 infection and the kidneys: Learning the lesson. https://pubmed.ncbi.nlm.nih.gov/34119846/

The information presented in this article is for informational purposes only and cannot replace professional medical advice. Always consult a specialist for the diagnosis and treatment of diseases.